1st Quarter - Report
340B HEALTH for 340B HEALTH
Firm
Client
Income
—
Expenses
$209,061
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
FY14 and FY 15 Labor-HHS Appropriations Bill, 340B Drug Discount Program Congressional Oversight, HRSA's expected 2014 Mega-Rule on 340B, cancer drug reimbursement, hospital reimbursement issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN COSTER | — |
| JEFFREY IRVING DAVIS | — |
| KATHRYN DIBITETTO | — |
| GREG DOGGETT | — |
| TED SLAFSKY | — |
| LIAM STEADMAN | — |
| MAUREEN TESTONI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.